Home The Word Brain My Amedeo FAQ Privacy About   


Amedeo C49

English + 你好 (nǐ hǎo) = limitless possibilities.
Start learning Mandarin Chinese today—for free, forever.

Amedeo C49 is completely free, for life. Next week: +49.


  Parkinson's Disease

  Free Subscription


Articles published in Neurosci Lett

Retrieve available abstracts of 55 articles:
HTML format



Single Articles


    October 2025
  1. TOGAWA K, Matsumoto S, Deng L, Jin M, et al
    DOPAnization of alpha-synuclein exacerbates dopaminergic neurodegeneration in the substantia nigra.
    Neurosci Lett. 2025;865:138354.
    PubMed     Abstract available


    August 2025
  2. WANG J, Hou J, Du M, Hou X, et al
    The mechanism of alpha-lipoic acid regulating dopaminergic neuronal damage in Parkinson's disease through the Nrf2/HMOX1 pathway.
    Neurosci Lett. 2025 Aug 3:138338. doi: 10.1016/j.neulet.2025.138338.
    PubMed     Abstract available


    July 2025
  3. DENG X, Zheng W, Xu H, Yang Y, et al
    Genetic analysis of TMEM230 variants in Han Chinese patients with Parkinson's disease.
    Neurosci Lett. 2025 Jul 29:138334. doi: 10.1016/j.neulet.2025.138334.
    PubMed     Abstract available


    May 2025
  4. SUGIYAMA K, Kuroiwa M, Shuto T, Hwang S, et al
    Subregion-specific suppression of dopamine D1 receptor expression prevents L-DOPA-induced dyskinesia in a mouse model of Parkinson's disease.
    Neurosci Lett. 2025 May 25:138273. doi: 10.1016/j.neulet.2025.138273.
    PubMed     Abstract available


  5. CORTES-ALTAMIRANO JL, Alfaro-Rodriguez A, Morraz-Varela A, Reyes-Long S, et al
    Changes in gene expression of D2 and D5 receptors in the thalamus and midbrain caused by a persistent painful stimulus in Parkinsonian rats.
    Neurosci Lett. 2025;859-861:138270.
    PubMed     Abstract available


    January 2025
  6. ORTEGA A, Laville A, Padilla-Orozco M, Parrado Y, et al
    Cortical beta oscillation in brain slices of hemi parkinsonian mice.
    Neurosci Lett. 2025;849:138128.
    PubMed     Abstract available


    October 2024
  7. ZHANG J, Dong M, Li Z, Li Z, et al
    Association of plasma neurofilament light chain and Lipoprotein-related phospholipase A2 with motor subtypes of Parkinson's disease.
    Neurosci Lett. 2024 Oct 16:138011. doi: 10.1016/j.neulet.2024.138011.
    PubMed     Abstract available


  8. VILLAMAR-FLORES CI, Rodriguez-Violante M, Abundes-Corona A, Alatriste-Booth V, et al
    Association between alterations in sleep spindles and cognitive decline in persons with Parkinson's disease.
    Neurosci Lett. 2024;842:138006.
    PubMed     Abstract available


    September 2024
  9. BAGWELL E, Shin M, Henkel N, Migliaccio D, et al
    1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated adult zebrafish as a model for Parkinson's Disease.
    Neurosci Lett. 2024;842:137991.
    PubMed     Abstract available


  10. JIANG M, Liu Y, Cao Y, Liu Y, et al
    Auxiliary diagnostic method of Parkinson's disease based on eye movement analysis in a virtual reality environment.
    Neurosci Lett. 2024 Sep 2:137956. doi: 10.1016/j.neulet.2024.137956.
    PubMed     Abstract available


    August 2024
  11. ZHANG W, Peng H, Yang D, Song G, et al
    Absence of motor impairments or pathological changes in TMEM230 knockout rats.
    Neurosci Lett. 2024;837:137921.
    PubMed     Abstract available


  12. FAN X, Tang Y, Wei Z, Shi F, et al
    Mitochondrial dysfunction and NDUFS3: Insights from a PINK1(B9) Drosophila model in Parkinson's disease pathogenesis.
    Neurosci Lett. 2024 Aug 3:137917. doi: 10.1016/j.neulet.2024.137917.
    PubMed     Abstract available


    July 2024
  13. CHEN J, Meng Q, Zhang Y, Liang Y, et al
    TrueTH: A user-friendly deep learning approach for robust dopaminergic neuron detection.
    Neurosci Lett. 2024;836:137871.
    PubMed     Abstract available


  14. HE Q, Zhou Y, Jin J, Tian Q, et al
    Association between NEK1 gene polymorphisms and the potential risk of sporadic Parkinson's disease in the Chinese Northern Han population: A case-control study.
    Neurosci Lett. 2024 Jul 18:137913. doi: 10.1016/j.neulet.2024.137913.
    PubMed     Abstract available


    June 2024
  15. MENG Q, Chen J, Liang Y, Zhang X, et al
    miR-142-3p alleviates neuronal apoptosis in Parkinson's disease via negatively regulating C9orf72.
    Neurosci Lett. 2024 Jun 26:137887. doi: 10.1016/j.neulet.2024.137887.
    PubMed     Abstract available


  16. MARANO M, Altavista MC, Cassetta E, Brusa L, et al
    The influence of sex on non-motor wearing-off in Parkinson's disease: A WORK-PD post-hoc study.
    Neurosci Lett. 2024 Jun 7:137850. doi: 10.1016/j.neulet.2024.137850.
    PubMed     Abstract available


    April 2024
  17. ZAMEER F, Jain P, Khan K, Pramod Kumar P, et al
    Unraveling the regulatory landscape of Parkinson disease: A molecular symphony of miRNAs, transcription factors, and high-risk genes.
    Neurosci Lett. 2024 Apr 25:137792. doi: 10.1016/j.neulet.2024.137792.
    PubMed     Abstract available


    March 2024
  18. LI Z, Liu J, Miao X, Ge S, et al
    Reorganization of structural brain networks in Parkinson's disease with postural instability/gait difficulty.
    Neurosci Lett. 2024 Mar 19:137736. doi: 10.1016/j.neulet.2024.137736.
    PubMed     Abstract available


    February 2024
  19. SARKAR S, Biswas A, Ansari S, Choudhury S, et al
    Association of dopamine receptor D3 polymorphism with Levodopa-induced Dyskinesia: A study on Parkinson's disease patients from India.
    Neurosci Lett. 2024;825:137706.
    PubMed     Abstract available


  20. ADLER CH, Serrano GE, Shill HA, Driver-Dunckley E, et al
    Symmetry of synuclein density in autopsied Parkinson's disease submandibular glands.
    Neurosci Lett. 2024;825:137702.
    PubMed     Abstract available


  21. TAKIZAWA S, Ohuchi K, Fujimaki A, Ito T, et al
    Effects of alpha7 nicotinic acetylcholine receptor agonist against alpha-synuclein-induced neurotoxicity.
    Neurosci Lett. 2024;823:137654.
    PubMed     Abstract available


  22. CAKIR M, Sacmaci H
    The relationship of salusins with Parkinson's Disease, Alzheimer's Disease, and acute ischemic stroke: A preliminary study.
    Neurosci Lett. 2024 Feb 11:137683. doi: 10.1016/j.neulet.2024.137683.
    PubMed     Abstract available


    January 2024
  23. LIU H, Gong Z, Li Z, Ye T, et al
    Distribution, connection and function of ALDH1A1(+)/TH(+) neurons in substantia nigra pars reticulata of mouse.
    Neurosci Lett. 2024;818:137555.
    PubMed     Abstract available


    December 2023
  24. HU Q, Xu L, Liu X, Wang Y, et al
    Adenosine A(2A) receptor antagonist KW6002 protects against A53T mutant alpha-synuclein-induced brain damage and neuronal apoptosis in Parkinson's disease mice by restoring autophagic flux.
    Neurosci Lett. 2023 Dec 27:137610. doi: 10.1016/j.neulet.2023.137610.
    PubMed     Abstract available


  25. HUANG W, Wang Y, Huang W
    Mangiferin alleviates 6-OHDA-induced Parkinson's disease by inhibiting AKR1C3 to activate Wnt signaling pathway.
    Neurosci Lett. 2023 Dec 22:137608. doi: 10.1016/j.neulet.2023.137608.
    PubMed     Abstract available


  26. RAJAN S, Sood A, Jain R, Kamatham PT, et al
    Fingolimod exerts neuroprotection by regulating S1PR1 mediated BNIP3-PINK1-Parkin dependent mitophagy in rotenone induced mouse model of Parkinson's disease.
    Neurosci Lett. 2023;820:137596.
    PubMed     Abstract available


    November 2023
  27. BILISTER EGILMEZ C, Azak Pazarlar B, Alper Erdogan M, Erbas O, et al
    Neuroprotective effect of dexpanthenol on rotenone-induced Parkinson's disease model in rats.
    Neurosci Lett. 2023 Nov 29:137575. doi: 10.1016/j.neulet.2023.137575.
    PubMed     Abstract available


  28. GUO F, Kang J, Xu J, Wei S, et al
    Genome-wide identification of m(6)A-associated single nucleotide polymorphisms in complex diseases of nervous system.
    Neurosci Lett. 2023;817:137513.
    PubMed     Abstract available


  29. SINGH A, Panhelainen A, Voutilainen MH
    Feasibility of combining alpha-synuclein aggregation and 6-OHDA in embryonic midbrain culture for modeling dopamine neuron degeneration.
    Neurosci Lett. 2023;816:137510.
    PubMed     Abstract available


  30. PAN Y, Zong Q, Li G, Wu Z, et al
    Nuclear localization of alpha-synuclein induces anxiety-like behavior in mice by decreasing hippocampal neurogenesis and pathologically affecting amygdala circuits.
    Neurosci Lett. 2023;816:137490.
    PubMed     Abstract available


    October 2023
  31. MONAGHAN AS, Hooyman A, Dibble LE, Mehta SH, et al
    Cognitive Predictors of Responsiveness to Reactive Step Training in People with Parkinson's Disease at Fall-Risk.
    Neurosci Lett. 2023;817:137517.
    PubMed     Abstract available


    September 2023
  32. STATZ M, Schleuter F, Weber H, Kober M, et al
    Subthalamic nucleus deep brain stimulation does not alter growth factor expression in a rat model of stable dopaminergic deficiency.
    Neurosci Lett. 2023;814:137459.
    PubMed     Abstract available


  33. GENG X, Zou Y, Li J, Li S, et al
    Mesenchymal stem cell exosomes rich in miR-23b-3p affect the Wnt signaling pathway and promote neuronal autophagy to alleviate PD symptoms.
    Neurosci Lett. 2023;814:137437.
    PubMed     Abstract available


    August 2023
  34. HEO EJ, Lee Y, Hyung Seo M, Yeo S, et al
    Association between SGK1 and alpha-synuclein in skeletal muscle in an MPTP-induced Parkinson's disease model.
    Neurosci Lett. 2023 Aug 25:137464. doi: 10.1016/j.neulet.2023.137464.
    PubMed     Abstract available


  35. KAPLAN ALGIN A, Tomruk C, Gozde Aslan C, Saban Akkurt S, et al
    Effects of ozone treatment to the levels of neurodegeneration biomarkers after rotenone induced rat model of Parkinson's disease.
    Neurosci Lett. 2023;814:137448.
    PubMed     Abstract available


  36. HE P, Gao Y, Shi L, Li Y, et al
    Motor progression phenotypes in early-stage Parkinson's Disease: A clinical prediction model and the role of glymphatic system imaging biomarkers.
    Neurosci Lett. 2023 Aug 8:137435. doi: 10.1016/j.neulet.2023.137435.
    PubMed     Abstract available


  37. TAN Z, Lin Y, Zhou M, Guo W, et al
    Correlation of SV2C rs1423099 single nucleotide polymorphism with sporadic Parkinson's disease in Han population in Southern China.
    Neurosci Lett. 2023 Aug 4:137426. doi: 10.1016/j.neulet.2023.137426.
    PubMed     Abstract available


    July 2023
  38. TIAN Q, Sun X, Li C, Yang Y, et al
    CD33 polymorphisms and Parkinson's disease Parkinson's disease in northern Chinese Han population: A case-control study.
    Neurosci Lett. 2023;812:137400.
    PubMed     Abstract available


  39. LI Y, Li F, Liu X, Zu J, et al
    Association between serum neurofilament light chain levels and sleep disorders in patients with Parkinson's disease.
    Neurosci Lett. 2023 Jul 10:137394. doi: 10.1016/j.neulet.2023.137394.
    PubMed     Abstract available


  40. JIN H, Shen H, Liu C, Wang L, et al
    Decreased Serum BDNF Contributes to the Onset of REM Sleep Behavior Disorder in Parkinson's Disease Patients.
    Neurosci Lett. 2023 Jul 7:137380. doi: 10.1016/j.neulet.2023.137380.
    PubMed     Abstract available


    June 2023
  41. HWAN SHIN J, Ah Shin D, Young Lee C, Jin Chang H, et al
    Inability to suppress head rotation during the saccade test as a clinical biomarker for cognitive dysfunction in Parkinson's disease.
    Neurosci Lett. 2023 Jun 22:137356. doi: 10.1016/j.neulet.2023.137356.
    PubMed     Abstract available


  42. ZHENG Q, Ma P, Yang P, Zhai S, et al
    Alpha lipoic acid ameliorates motor deficits by inhibiting ferroptosis in Parkinson's disease.
    Neurosci Lett. 2023 Jun 10:137346. doi: 10.1016/j.neulet.2023.137346.
    PubMed     Abstract available


    May 2023
  43. WANG X, Wei W, Bai Y, Shen Y, et al
    Intrinsic Brain Activity Alterations in Patients With Parkinson's disease.
    Neurosci Lett. 2023 May 15:137298. doi: 10.1016/j.neulet.2023.137298.
    PubMed     Abstract available


    April 2023
  44. ZHANG X, Zhong X, Wang L, Li H, et al
    Effects of soluble TREM2 on motor progression in Parkinson's disease.
    Neurosci Lett. 2023 Apr 25:137277. doi: 10.1016/j.neulet.2023.137277.
    PubMed     Abstract available


  45. ZHANG X, Li L, Qi L, Fu Y, et al
    Distribution pattern of iron deposition in the basal ganglia of different motor subtypes of Parkinson's disease.
    Neurosci Lett. 2023 Apr 13:137249. doi: 10.1016/j.neulet.2023.137249.
    PubMed     Abstract available


  46. SHIDA TKF, de Oliveira CEN, da Silva Fragoso de Campos D, Los Angeles E, et al
    Effect of freezing of gait and dopaminergic medication in the biomechanics of lower limbs in the gait of patients with Parkinson's disease compared to neurologically healthy.
    Neurosci Lett. 2023;806:137250.
    PubMed     Abstract available


  47. MURAKAMI Y, Nishijima H, Nakamura T, Furukawa T, et al
    Altered amantadine effects after repetitive treatment for l-dopa-induced involuntary movements in a rat model of Parkinson's disease.
    Neurosci Lett. 2023;806:137248.
    PubMed     Abstract available


  48. DONG L, Chang Q, Ma J, Liu C, et al
    Associations of blood UCH-L1 and NfL levels with cognitive dysfunction in Parkinson's disease patients.
    Neurosci Lett. 2023;804:137219.
    PubMed     Abstract available


  49. MA C, Wei X, Wang F, Zhang T, et al
    Tumor necrosis factor alpha-induced protein 3 mediates inflammation and neuronal autophagy in Parkinson's disease via the NFkappaB and mTOR pathways.
    Neurosci Lett. 2023 Apr 3:137223. doi: 10.1016/j.neulet.2023.137223.
    PubMed     Abstract available


  50. MORRISON S, Reilly N, Schussler E, Kerr G, et al
    The effect of standing posture on amplitude and variability of postural tremor in Parkinson's disease.
    Neurosci Lett. 2023 Apr 3:137220. doi: 10.1016/j.neulet.2023.137220.
    PubMed     Abstract available


  51. YUAN M, Du N, Song Z
    Primary motor area-related injury of anterior central gyrus in Parkinson's disease with dyskinesia: a study based on MRS and Q-Space.
    Neurosci Lett. 2023 Apr 3:137224. doi: 10.1016/j.neulet.2023.137224.
    PubMed     Abstract available


    March 2023
  52. GOMEZ-MARTIN A, Fuentes JM, Jordan J, Galindo MF, et al
    Detection of rare Genetic Variations in the promoter regions of the ATG16L gene in Parkinson's patients.
    Neurosci Lett. 2023 Mar 21:137195. doi: 10.1016/j.neulet.2023.137195.
    PubMed     Abstract available


  53. LI W, Pan X, Li M, Ling L, et al
    Impact of age on the rotenone-induced sporadic Parkinson's disease model using Drosophila melanogaster.
    Neurosci Lett. 2023 Mar 13:137187. doi: 10.1016/j.neulet.2023.137187.
    PubMed     Abstract available


    February 2023
  54. OMAR AHMAD S, Longhurst J, Stiles D, Downard L, et al
    A meta-analysis of exercise intervention and the effect on Parkinson's Disease Symptoms.
    Neurosci Lett. 2023 Feb 28:137162. doi: 10.1016/j.neulet.2023.137162.
    PubMed     Abstract available


  55. CARNEY AE, Clarke C, Pratt WE
    Administration of neuropeptide Y into the rat nucleus accumbens shell, but not core, attenuates the motivational impairment from systemic dopamine receptor antagonism by alpha-flupenthixol.
    Neurosci Lett. 2023;797:137069.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Parkinson's Disease is free of charge.